Previous Page  4 / 13 Next Page
Information
Show Menu
Previous Page 4 / 13 Next Page
Page Background

Volume 3

Journal of Nursing Research and Practice

Nursing and Heart 2019

April 22-23, 2019

Page 13

Notes:

Nursing Education and Evidence Based Practice Conference

Heart Conference

April 22-23, 2019 Dubai, UAE

World

4

th

International

&

Samer Ellahham, J Nursing Research and Practice, Volume 3

DOI: 10.4172/2632-251X-C3-007

Samer Ellahham

Cleveland Clinic, UAE

Reducing heart failure readmission

T

he cost of heart failure care is 1-2% overall healthcare spending in developed countries. In the United States, heart

failure consumes more medicare dollars than any other diagnosis. Diabetes mellitus and preserved ejection fraction are

independent predictors of higher lifetime costs. Costs are accrued more rapidly at the time of initial diagnosis and in the final

months of life. The incidence of heart failure is high and increases with age. Readmission is an issue with heart failure the burden

of hospitalization is increasing. Heart failure is deadly and costly – with much of the cost due to the burden of hospitalization.

Effective evidence-based interventions should address gaps in care and promote effective transitions across sites and clinicians

(e.g., single point person throughout episode of illness, transfer of information, focused patient/family caregiver education,

coordinated follow-up services), and root causes of poor outcomes with a focus on longer-term value for both the patient and

health care system. A heart failure readmission checklist before admission, during hospitalization, and related to discharge. In

summary a checklist and disease management program are key to reducing heart failure hospital readmission.

Biography

Samer Ellahham is a board-certified Internist, Cardiologist and Vascular Medicine Senior Consultant. He is a Fellow of theAmerican College of Cardiology and key member

in heart failure and transplant, adult congenital and pediatric cardiology, cardio-oncology and peripheral vascular disease sections. He is the Eminent Editor of The Journal

of Cardiology & Cardiovascular Therapy. He has served as Chief Quality Officer for SKMC since 2009. His research includes innovation, digital healthcare solutions, tele-

medicine, block chain, patient experience and engagement, lean six sigma, change management, innovation, safety, risk management, KPI management, safe surgery,

heart failure, molecular biology, genetics, cardiac imaging, sports and nutrition. He is a recognized world-leader in these fields.

samerellahham@yahoo.com